Cannabis and skin cancer
Browse the latest research linking medical marijuana / medicinal cannabis and skin cancer.

See also: cancer 
Click on a study title below to open a new tab with full article, or click on a compound to see it's full list of research.
Compounds Topics Title Date
CBD anti-inflamatory,skin cancer in vitro Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury Jun 2019
Down-regulation of genes involved in wound healing and skin inflammation was at least in part due to the presence of cannabidiol. Our findings provide new insights into the potential effect of Cannabisextracts against inflammation-based skin diseases.
WIN55,JWH-133 cancer,skin cancer in mice via experiment Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors Jan 2003
Action Pathway: CB2
Local administration of the mixed CB1/CB2 agonist WIN-55,212-2 or the selective CB2 agonist JWH-133 induced a considerable growth inhibition of malignant tumors generated by inoculation of epidermal tumor cells into nude mice
cannabinoids cancer,skin cancer via review The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities Jul 2009
Collectively, it seems that the main physiological function of the cutaneous ECS is to constitutively control the proper and well-balanced proliferation, differentiation and survival, as well as immune competence and/or tolerance, of skin cells.
cannabinoids cancer,skin cancer in mice Cannabinoid receptors as novel targets for the treatment of melanoma. Dec 2006
Here, we evaluated the efficacy of cannabinoid receptor agonists, a new family of potential antitumoral compounds, at skin melanoma. Human melanomas and melanoma cell lines express CB1 and CB2 cannabinoid receptors. Activation of these receptors decreased growth, proliferation, angiogenesis and metastasis, and increased apoptosis, of melanomas in mice.